Search
for
Sort by
Research 31–60 of 75
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Development of a Doxazosin and Finasteride Transdermal System for Combination Therapy of Benign Prostatic Hyperplasia
- Current Concepts and Translational Uses of Platelet Rich Plasma Biotechnology
- A symphony of signals: the intricate role of lncRNAs in dermatological disorders
- Alopesi Areata ile Depresyon İlişkisi
- Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia
- Hair loss during and after breast cancer therapy
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Supportive Cryotherapy: A Review From Head to Toe
- Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature
- Scalp cooling to prevent chemotherapy-induced alopecia
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
- Oral minoxidil for late alopecia in cancer survivors
- Cooling-mediated protection from chemotherapy drug-induced cytotoxicity in human keratinocytes by inhibition of cellular drug uptake
- Patient-reported outcome assessment and objective evaluation of chemotherapy-induced alopecia
- Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling
- Hair safe study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer patients receiving chemotherapy - A prospective interventional study
- Therapeutic Effect of Superficial Scalp Hypothermia on Chemotherapy-Induced Alopecia in Breast Cancer Survivors
- Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer
- Prevention of chemotherapy drug-mediated human hair follicle damage: combined use of cooling with antioxidant suppresses oxidative stress and prevents matrix keratinocyte cytotoxicity
- The effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial
- Impact of a topical lotion, CG428, on permanent chemotherapy-induced alopecia in breast cancer survivors: a pilot randomized double-blind controlled clinical trial (VOLUME RCT)
- Racial and Ethnic Disparities in Persistent Chemotherapy-Induced Alopecia Among Women With Breast Cancer
- Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy
- Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique
- Efficacy of Scalp Cooling System Versus Chemical Cooling Cap in Preventing Chemotherapy-induced Alopecia in Breast Cancer (COHAIR Study): a prospective randomized trial
- Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data
- Formulation and characterisation of resveratrol-loaded nanostructured lipid carriers for use in combination with scalp cooling therapy to mitigate chemotherapy-induced follicular cytotoxicity and hair loss
- Cancer-Related Alopecia Risk and Treatment